D&D Pharmatech Co., Ltd.
No trades
−800 KRW
−28.62 B KRW
11.44 B KRW
19.31 M
About D&D Pharmatech Co., Ltd.
Sector
Industry
CEO
Seul-Ki Lee
Website
Headquarters
Seongnam-si
Founded
2014
IPO date
May 2, 2024
IPO offer price
23.87 USD
Identifiers
2
ISINKR7347850000
D&D Pharma Tech Co., Ltd. engages in drug research and development. It develops medicines for metabolic, degenerative brain, and fibrotic diseases. The company was founded by Seul-Ki Lee, Seong-Mook Im and Kang Choon Lee on November 28, 2014 and is headquartered in Suwon, South Korea.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 347850 is 89,300 KRW — it has decreased by −3.37% in the past 24 hours. Watch D&D Pharmatech Co., Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange D&D Pharmatech Co., Ltd. stocks are traded under the ticker 347850.
347850 stock has fallen by −5.53% compared to the previous week, the month change is a 4.10% rise, over the last year D&D Pharmatech Co., Ltd. has showed a 604.54% increase.
347850 reached its all-time high on Nov 24, 2025 with the price of 113,700 KRW, and its all-time low was 6,300 KRW and was reached on Jun 27, 2024. View more price dynamics on 347850 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
347850 stock is 4.85% volatile and has beta coefficient of 1.44. Track D&D Pharmatech Co., Ltd. stock price on the chart and check out the list of the most volatile stocks — is D&D Pharmatech Co., Ltd. there?
Today D&D Pharmatech Co., Ltd. has the market capitalization of 3.87 T, it has increased by 3.08% over the last week.
Yes, you can track D&D Pharmatech Co., Ltd. financials in yearly and quarterly reports right on TradingView.
347850 net income for the last quarter is −5.64 B KRW, while the quarter before that showed −9.87 B KRW of net income which accounts for 42.81% change. Track more D&D Pharmatech Co., Ltd. financial stats to get the full picture.
No, 347850 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 24, 2025, the company has 24 employees. See our rating of the largest employees — is D&D Pharmatech Co., Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. D&D Pharmatech Co., Ltd. EBITDA is −24.86 B KRW, and current EBITDA margin is −170.42%. See more stats in D&D Pharmatech Co., Ltd. financial statements.
Like other stocks, 347850 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade D&D Pharmatech Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So D&D Pharmatech Co., Ltd. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating D&D Pharmatech Co., Ltd. stock shows the neutral signal. See more of D&D Pharmatech Co., Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.